Agnija Kivrane

发表

LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.

Dace Bandere, S. Grinberga, O. Pugovics, 2021, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Telomere length and mitochondrial DNA copy number in multidrug-resistant tuberculosis.

R. Ranka, E. Zole, Agnija Kivrane, 2021, Tuberculosis.

Next-Generation Sequencing and Bioinformatics-Based Protocol for the Full-Length CYP2E1 Gene Polymorphism Analysis

R. Ranka, Agnija Kivrane, Viktorija Igumnova, 2022, Pharmacogenomics and personalized medicine.

PGPM_A_371709 959..965

R. Ranka, Agnija Kivrane, Viktorija Igumnova, 2022 .

Tick-borne pathogens in ticks collected from dogs, Latvia, 2011–2016

I. Berzina, R. Ranka, Agnija Kivrane, 2019, BMC Veterinary Research.

Development of a real-time PCR method for rapid diagnosis of canine babesiosis and anaplasmosis

R. Ranka, Agnija Kivrane, Valentina Capligina, 2021, Parasites & vectors.

Large-scale countrywide screening for tick-borne pathogens in field-collected ticks in Latvia during 2017–2019

A. Bormane, R. Ranka, Agnija Kivrane, 2020, Parasites & Vectors.

Oral microbiome variations related to ageing: possible implications beyond oral health

P. Zayakin, R. Ranka, Agnija Kivrane, 2023, Archives of Microbiology.

Development of rapid antigen test prototype for detection of SARS-CoV-2 in saliva samples

A. Kazaks, R. Ranka, A. Reinis, 2022, Upsala journal of medical sciences.

Babesiosis in Latvian domestic dogs, 2016-2019.

R. Ranka, Agnija Kivrane, Valentina Capligina, 2020, Ticks and tick-borne diseases.

Assessment of Amikacin- and Capreomycin-Related Adverse Drug Reactions in Patients with Multidrug-Resistant Tuberculosis and Exploring the Role of Genetic Factors

R. Ranka, Agnija Kivrane, Lauma Freimane, 2023, Journal of personalized medicine.

Comparative Microbiome Analysis of Three Epidemiologically Important Tick Species in Latvia

A. Bormane, R. Ranka, Agnija Kivrane, 2023, Microorganisms.

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic Perspective

S. Grinberga, Eduards Sevostjanovs, M. Zolovs, 2024, Pharmaceutics.

Effect of NAT2, GSTM1 and CYP2E1 genetic polymorphisms on plasma concentration of isoniazid and its metabolites in patients with tuberculosis, and the assessment of exposure-response relationships

Dace Bandere, S. Grinberga, Leonora Pahirko, 2024, Frontiers in pharmacology.